INTRODUCTION
Cryptozoospermia is defined as very few sperm cells in ejaculation that is difficult to measure without extended microscopic search (Bendikson et al., 2008; Hauser et al., 2011) . In vitro fertilization (IVF) through intracytoplasmic sperm injection (ICSI) is the most commonly adopted assisted reproductive technology for patient with cryptozoospermia. The only prerequisite for ICSI is the presence of at least one spermatozoon per oocyte.
However, controversy has existed for years over using testicular or ejaculated sperm for ICSI to achieve best clinical outcome, especially regarding miscarriage and take-home baby rate.
The ejaculated sperm is thought to be more mature than testicular sperm and may lead to a better ICSI outcome. However, it has been proposed that the oxidative stress alone in the genital tract and during preparation of ejaculated sperm could result in nuclear deoxyribonucleic acid (DNA) damage, lowering the sperm quality and ICSI outcome (Aitken & Krausz, 2001; Suganuma et al., 2005) . On the other hand, testicular sperm extraction may eliminate the exposure of spermatozoa to oxygen and allow access to high quality spermatozoa, leading to better fertility outcome. Patients receiving surgical retrieval of spermatozoa may be at risk of pain, swelling, hydrocele or hematoma and the incidence rate of complication ranged from 0% to 70% (Esteves et al., 2013) . For clinicians, there is no evidence strong enough to guide the usage of ejaculated or testicular sperm for ICSI in patients with cryptozoospermia. While using testicular sperm may have better fertility outcome, the use of ejaculated sperm could avoid unnecessary surgical complications. If there is no significant fertility benefit in using testicular sperm, ejaculated sperm may be suggested given its low risk of complication and more mature sperm.
Several cohort studies have been conducted to clarify whether there is significant advantage of using testicular sperm over ejaculated sperm in patient with cryptozoospermia (Bendikson et al., 2008; Hauser et al., 2011; Amirjannati et al., 2012; BenAmi et al., 2013; Cui et al., 2016; Ketabchi, 2016) , and to our knowledge there are two systematic reviews on this topic in recent years (Abhyankar et al., 2016; Kang et al., 2018) . The first systematic review that was published in 2016 enrolled five studies-four cohort studies (Amirjannati et al., 2012; Ben-Ami et al., 2013; Bendikson et al., 2008; Hauser et al., 2011) and one case report (Weissman et al., 2008) (Abhyankar et al., 2016) . The systematic review conducted meta-analysis from 272 ICSI cycles with 2547 transplanted embryos and concluded no differences in the pregnancy rate and fertilization rate between the two sperm sources. After the study, our team conducted the second systematic review, an update meta-analysis, in 2018 (Kang et al., 2018) . In our previous work, we successfully identified six cohort studies on this topic and performed meta-analysis from 578 male infertility patients with 761 ICSI cycles (Bendikson et al., 2008; Hauser et al., 2011; Amirjannati et al., 2012; Ben-Ami et al., 2013; Cui et al., 2016; Ketabchi, 2016; Kang et al., 2018) . In the work, we would like to respond to the first systematic review on this topic by providing an update and correct evidence. Although the update evidence indicated that testicular sperm is superior to ejaculated sperm in good embryo quality rate, implantation rate, and pregnancy rate, the synthesized evidence did not compare the miscarriage rate and take-home baby rate, which may also be influenced by the quality of spermatozoa and embryos. These two outcomes are the most important to patients. To further clarify the issue and provide solid evidence to guide the clinical decision making, we conducted this metaanalysis, which was based on systematic review to take a step forward on this topic. The aim of this study was to compare the miscarriage rate and take-home baby rate of ICSI using testicular sperm and ejaculated sperm in patient with cryptozoospermia.
MATERIALS AND METHODS
The present study performed meta-analysis according to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses guidelines (Moher et al., 2009) . This study registered online with PROSPERO (CRD42017068410).
Inclusion and exclusion criteria
Two investigators (Kang and Wu) individually identified the relevant evidence by using a priori criteria. Inclusion criteria included (i) men with cryptozoospermia, (ii) treating with ICSI, and (iii) comparing testicular sperm with ejaculated sperm. The exclusion criteria were as follows: (i) infertility conditions mixed cryptozoospermia along with other disease (azoospermia, asthenozoospermia, teratozoospermia), or (ii) sperm retrieval were mixed testis and other source. Any disagreement regarding article eligibility was resolved through discussions.
Data sources and search strategy
We performed electronic database searches for potential studies in the Cochrane Database (including CENTRAL), Embase, Ovid Medline, PubMed, ScienceDirect, Scopus, and Web of Science. The searches used relevant terms of cryptozoospermia, ICSI, testicular, and ejaculated. The keyworks included both natural language and medical subject heading (MeSH term in PubMed and Emtree in Embase). We combined synonyms by using Boolean algebra "OR", and connected concepts by using "AND". No restriction of publication data or language was set in systematic searches. The final searches were completed before 28 th Jun 2018 (Appendix S1).
The two investigators screened the potential studies through two steps. In the first step, we screened title and abstract according to inclusion criteria. In the second step, we retrieved full-text of remaining studies, and reviewed the full-text according to exclusion criteria.
Quality assessment
This study assessed quality of included studies by using the appraisal tool of the Newcastle-Ottawa Quality Assessment Scale. This Scale was developed for evaluation of bias in observational study with eight methodological domains. The eight domains are categorized in three parts. The first part assesses bias in population selection (five points). The second part assesses bias of comparability with one item (two points). The third part assesses bias in outcome assessment with three items (three points). Two of authors (Hsiao and Ku) critically reviewed all the included studies independently, and the third author participated in discussion and resolved disagreements (Kang) .
Data extraction
Two investigators (Hsiao and Wu) independently identified the relevant information and outcome data. The relevant information included first author's name, publication year, country, study period, number of patients, number of ICSI cycles, embryo transfers, pregnancy, paternal age, and maternal age, ovulation method, period of ovulation trigger to oocyte aspiration, and assessment of oocyte maturity. The outcome data included miscarriage and take-home baby. The miscarriage and take-home baby was extracted in dichotomous data.
Statistical analysis
We conducted quantitative synthesis through meta-analysis. In meta-analysis, we choose risk ratio (RR) to estimate the effect of miscarriage and take-home baby between different sperm sources. Because some differences of population and treatment may exist among observational studies, we mainly demonstrated meta-analysis in random-effects model and supplemented the results of fixed-effect model in Supporting Information. The result of meta-analysis was expressed as forest plot with RR, 95% confidence intervals (CI).
To examine heterogeneity in meta-analysis, we estimated tausquare, chi-square, and I-square. I-square is the most common in demonstrating heterogeneity because it presents the percentage of the total variation across the pooled studies. We assumed high heterogeneity when the value of I-square was 75%, or when p value of tau-square was lower than 0.10 (Higgins et al., 2003) . Small study bias was detected by funnel plot with Egger's test. The outcome remains room for discussion when the heterogeneity is high or small study bias exists in the meta-analysis.
To guarantee the effect, we conducted sensitivity analysis. The sensitivity analysis indicates the effect sizes if each study is deleted. The outcome should be carefully interpreted when the sensitivity differs from overall pooling. To clarify the effect, we further conducted subgroup analyses by pregnancies, ICSI cycles, and embryo transfers separately. We also conducted subgroup analyses by mean age. According to available data, we divided two subgroups by paternal and maternal mean age. When paternal mean age was higher than 35 years old, we categorized in a subgroup of older males. In contrast, we categorized a subgroup of younger males when the paternal mean age was lower than 35 years old. Likewise, in a subgroup of maternal mean age, we categorized a subgroup of older females when maternal mean age was higher than 30 years old. When maternal mean age was lower than 30, we categorized in a subgroup of younger females.
The relevant analyses were completed in two software, Review Manager (version 5.3, The Cochrane Collaboration, Oxford, UK) and Comprehensive Meta-Analysis (version 2). We used Review Manager to analyse head-to-head meta-analyses and used Comprehensive Meta-Analysis to estimate sensitivity analysis and small study bias through funnel plot and Egger's test.
RESULTS

Search results
This study identified 331 citations in which 330 were from databases and one from hand search. The citations from Cochrane database (including CENTRAL), Embase, Ovid Medline, PubMed, ScienceDirect, Scopus and Web of Science were 5, 54, 80, 25, 53, 77 and 36, respectively. After removal of duplicate citations (n = 89), 226 of 242 remaining citations were excluded because they were non-relevant studies (n = 163), different comparisons (n = 20), different disease conditions (n = 8), conference reports (n = 7), not cohort study (n = 6) and other documents (n = 22) according to title and abstract in the first step of study selection. Then we retrieved full-text of the remaining 16 citations. After full-text review, we excluded 12 citations. These 12 citations are different disease conditions (n = 2), no reporting on miscarriage or take-home baby (n = 3), case-controlled study (n = 1), systematic review (n = 3), letter to editor (n = 1) and editorial comment (n = 2). Four cohort studies were included in the qualitative and quantitative synthesis (Bendikson et al., 2008; Hauser et al., 2011; Ben-Ami et al., 2013; Cui et al., 2016) .The process of study selection was shown in Fig. 1 .
Overview of included studies
This study included four cohort studies that included 331 patients with 479 ICSI cycles (Bendikson et al., 2008; Hauser et al., 2011; Ben-Ami et al., 2013; Cui et al., 2016) . The characteristics of included studies listed in Table 1 consisted of study country, study period, sample size, paternal and maternal age, ovulation method, period of ovulation trigger to oocyte aspiration, assessment of oocyte maturity, as well as risk of bias. These studies converted about 17 years that were from 1996 to 2013 in China (Cui et al., 2016) , Israel (Hauser et al., 2011; Ben-Ami et al., 2013) and USA (Bendikson et al., 2008) . Mean paternal ages in each study were from 34.25 to 36.83; and mean maternal ages in each study were between 28.44 and 33.59. The most common method for ovulation used human chorionic gonadotropin. The lag period between ovulation trigger to oocyte aspiration was approximately 35 h. The included studies defined oocyte maturity by metaphase II. Overall, these four cohort studies were well-designed and performed good quality in methodology (Appendix S2).
Primary outcome
The meta-analysis conducted miscarriage by pregnancy. Two studies recruiting 302 patients with 338 ICSI cycles reported miscarriage (Ben-Ami et al., 2013; Cui et al., 2016) . The pooled estimate of miscarriage demonstrated no significant difference between testicular sperm group and ejaculated sperm group (RR = 1.06, 95% CI: 0.48-2.35, p = 0.88) (Fig. 2, 1.1.1) . No heterogeneity in the meta-analysis of miscarriage were detected (I-square = 0%; p = 0.61). Similar results were found in fixedeffect model (Appendix S3). The two analysis models confirmed that the result of miscarriage rates was no difference between testicular sperm and ejaculated sperm. The present study did not conduct sensitivity analysis and Egger's test for miscarriage rates, because only two studies were included into quantitative synthesis.
The meta-analysis conducted take-home babies by pregnancy, embryo transfer and ICSI cycle. Four studies with 331 patients with 479 ICSI cycles reported the information of pregnancy, embryo transfer, ICSI cycle and take-home baby (Bendikson et al., 2008; Hauser et al., 2011; Ben-Ami et al., 2013; Cui et al., 2016) . The pooled estimate of take-home babies by pregnancies showed no difference between testicular sperm group (53/68, 77.94%) and ejaculated sperm group (59/72, 81.94%) (RR = 0.97, 95% CI: 0.83-1.14, p = 0.72) (Fig. 3, 1.2.1) . However, the pooled result of take-home babies by embryo transfers showed that testicular sperm group (53/226, 23.45%) had higher take-home baby rate than ejaculated sperm group (59/429, 13.75%) (RR = 1.72, 95% CI: 1.21-2.44, p = 0.002) (Fig. 3, 1.2.2) . The pooled data of take-home babies by ICSI cycles also showed that testicular sperm group (53/184, 28.80%) had higher take-home baby rate than ejaculated sperm group (59/295, 20.00%) (RR = 1.77, 95% CI: 1.28-2.44, p = 0.0005) (Fig. 3, 1.2.3 ). All the heterogeneities among studies in the meta-analyses of takehome baby rates were very low (I-square = 0%, p > 0.05). Similar results were found in fixed-effect model (Appendix S4). The two meta-analysis models confirmed that testicular sperm group had higher take-home babies by embryo transfers and by ICSI cycles than ejaculated sperm group. Small study bias in the above meta-analyses was not detected (Appendices S5-S7).
Further analysis
We further conducted sensitivity analysis and analysed takehome baby rate by subgroup of mean age. In the sensitivity analysis for take-home babies per pregnancy, the results showed that no significant difference between two sperm sources when 884 Andrology, 2018, 6, 882-889 any included study was removed from the meta-analysis (Appendix S8). In contrast, testicular sperm was significantly better than ejaculated sperm in the sensitivity analysis for takehome babies per embryo transfer (Appendix S9). Similarly, testicular sperm was also significantly better than ejaculated sperm in all sensitivity analysis for take-home babies per ICSI cycle (Appendix S10). These results are coherent with overall pooling and indicate that the results are reliable.
Regarding to further subgroup analysis of mean age, the studies investigated in older male (mean age ≥ 35) were also investigated in older female (mean age ≥ 30) (Bendikson et al., 2008; Hauser et al., 2011) . Similarly, the studies investigated in younger male (mean age < 35) were also investigated in younger female (mean age < 30) (Ben-Ami et al., 2013; Cui et al., 2016) . Therefore, we divided the studies into subgroups of older couple and younger couple in study-level. In the further analyses, we also estimated take-home baby rate by pregnancy, embryo transfer, and ICSI cycle respectively. In the estimation of takehome babies per pregnancy, the further analysis showed no significant difference between two sperm sources in both subgroups of older couple (RR = 0.88, 95% CI: 0.67-1.16, p = 0.37) (Fig. 4, 1.3 .1) and younger couple (RR = 1.02, 95% CI: 0.84-1.24, p = 0.84) (Fig. 4, 1.3.2) . These results are similar to the overall pooling in Fig. 3, 1. 2.1. However, in take-home babies per embryo transfer and per ICSI cycle, the results of older couple subgroup differ from the overall pooling. The subgroup of older couple showed no significant difference between two sperm sources in both estimations, take-home babies per embryo transfer (RR = 1.60, 95% CI: 0.78-3.25, p = 0.84) (Fig. 4, 1.3.3 ) and take-home baby per ICSI cycle (RR = 1.68, 95% CI 0.82-3.47, p = 0.16) (Fig. 4, 1.3.5) . In contrast, the subgroup of younger couple indicated that testicular sperm had significantly higher take-home baby rates than ejaculated sperm group in both estimations, take-home babies per embryo transfer (RR = 1.83, 95% CI: 1.11-3.03, p = 0.02) (Fig. 4, 1.3.4) and take-home baby per ICSI cycle (RR = 1.93, 95% CI: 1.11-3.34, P = 0.02) (Fig. 4, 1.3.6) . Similar results were found in fixed-effect model (Appendix S11).
DISCUSSION
Although the present evidence showed no difference in miscarriage rates between the two sperm sources, we found that testicular sperm is more favourable in take-home baby rates than Figure 1 Flow diagram of evidence selection according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. [Colour figure can be viewed at wileyonlinelibrary.com] ejaculated sperm, especially in younger couple. In all the four studies included, the testicular sperm group contained more take-home baby than the ejaculated sperm group. Our findings are similar to previous study that reporting take-home baby rate favouring the use of testicular over ejaculated sperm (46.7% vs. 26.4%, p = 0.007) in patients with azoospermia (Esteves et al., 2015) . Likewise, in a systematic review of normo-and oligospermic men with high sperm DNA fragmentation levels undergoing ICSI with either testicular or ejaculated sperm, take-home baby rate were higher in the testicular group with lower miscarriage rate (Esteves et al., 2017) . In contrast, in an earlier study comparing the ICSI outcome of testicular, epididymal and ejaculated sperm, there was comparable take-home baby rate per embryo transfer in the ejaculated sperm group and epididymal sperm group and a lower rate in the testicular sperm group. (21%, 22%, 10% respectively) (Ghazzawi et al., 1998) .
These results were in favour of the hypothesis that spermatozoa suffered from post-testicular damage through urogenital tract during the passage. The DNA damages were related to oxygen-free radicals and could result in poor embryo quality, leading to an inferior IVF outcome (Henkel et al., 2010; Shiva et al., 2011) . The testicular spermatozoa were found to have three times lower DNA damage than that of ejaculated sperm in male patients with high DNA fragmentation index and failed antioxidant treatment (Moskovtsev et al., 2010) . Similarly, in a prospective cohort study by Esteves et al. investigating the correlation between sperm DNA fragmentation and ICSI outcome, there was lower DNA fragmentation (8.3% vs. 40.7%), higher takehome baby rate (46.7% vs. 26.4%) and lower miscarriage rate (10.0% vs. 34.3%) in the testicular sperm group than the ejaculated sperm group (Esteves et al., 2015) In our study, there were higher take-home baby rate calculated by ICSI cycle and embryo transfer in the testicular arm than the ejaculated arm. It might be the result of higher DNA damage in the ejaculated sperm, leading to a decreased implantation rate and lower take-home baby rate.
On the other hand, the take-home baby calculated by pregnancy did not show any statistical significance favouring either testicular or ejaculated sperm. The result was similar to an observational study focusing on the association of the quality of transferred embryo and perinatal outcomes, in which the lower clinical pregnancy rate is observed in the poor embryo quality group. However, there was no statistical difference in the take-home baby rate in the two groups (Nakagawa et al., 2016) . It might be due to the fact that after successful implantation of the embryo, maternal factors would also influence the foetal growth and take-home baby, which masked the effect of different sperm source on the quality of embryo and well-being of the foetus. Another explanation for this phenomenon was that the implantation of embryos served as a "check-point" in the assisted reproduction process. Despite that ejaculated sperm had higher DNA fragmentation rate than testicular sperm, the degree of damage varied among spermatozoas and could still result in embryos with good enough quality for successful implantation and become clinical pregnancy. Therefore, there were no statistical differences of the take-home baby rate calculated by pregnancy between the two sperm source, since embryos with poor quality would not lead to clinical pregnancy.
The results in our study also showed no statistical difference in miscarriage rate per pregnancy regardless of sperm source. The finding corroborates our analysis of take-home baby rate that was calculated by per pregnancy. Those embryos with good enough quality would be able to reach clinical pregnancy, and if some of those embryos were later lost, they would be defined as miscarriage in our study. On the contrary, those embryos with poor quality, which in part caused by different sperm source, could not implant successfully and would not be calculated. Besides, after successful implantation, the maternal factor would also affect miscarriage rate, leading to a heterogeneous outcome. It is to say, a cumulative difference in estimation of take-home baby rate is from ICSI cycles through embryo transfers and implantations to pregnancies. Therefore, discussion on takehome baby rate should not ignore the cumulative effect and should not rely on per pregnancy only. Our findings demonstrated that different sperm sources had limited effect on the take-home baby rate after the embryo had achieved clinical pregnancy.
This meta-analysis has some limitations. First, the miscarriage rate was not completely assessed in all included studies. The pooled result of miscarriage from only two studies may not robust enough statistically. Second, no prospective study on this topic was found. Retrospective cohort studies have some inevitable limitation on methodology. The methodological limitations of retrospective study involve difference in population characteristics and treatments. As we were challenged by paucity of details on sperm retrieval and management, we could not well conduct stratified analyses based on sperm surgical procedures. Therefore, prospective study with a sufficient sample is needed to guarantee the results in our study.
To our knowledge, we conducted the first meta-analysis comparing testicular sperm and ejaculated sperm from patients with cryptozoospermia for the topic of miscarriage rate and take-home baby rate through ICSI. We found that for cryptozoospermia, take-home baby rate is higher in the testicular sperm group than ejaculated sperm group, especially with a trend toward younger couples. Given the Figure 3 Forest plot of meta-analysis of the take-home baby rates. [Colour figure can be viewed at wileyonlinelibrary.com] paucity of data on complications of testicular sperm vs. ejaculated sperm, as well as the lack of data in our analyses for surgical details, the findings of this study should be interpreted cautiously. Well-designed cohort studies are needed to test the complications of testicular sperm vs. ejaculated sperm among different sperm retrieval procedures. Then, we may know how to improve shared decision making and clinical practice for the male with cryptozoospermia.
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